《大行報告》美銀證券上調海爾智家(06690.HK)目標價至42.2元 評級「買入」
美銀證券發表研究報告指,海爾智家(06690.HK)上半年收入及毛利率增長較同業優勝,預期產品高端化、本地化策略及經營效率提升將繼續為下半年帶來增長動力,因此將2021至2022年每股盈利預測上調4%至5%。
該行指,管理層預期下半年來自中國及海外市場的收入可持續錄得雙位數增長,7月至8月份銷售表現符合預期,毛利率估計與上半年持平,按年則有提升,並預期中線而言,中國及海外市場經營溢利率將可分別達到10%以上及7%-8%。
美銀指出,海爾智家的股價自2月初的高位累計回落28%,現價水平對應2022年預測市盈率的14倍,接近歷史平均值,將目標價升至42.2元,重申「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.